Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Resmed (RSMDF) Current Assets (2016 - 2025)

Historic Current Assets for Resmed (RSMDF) over the last 16 years, with Q4 2025 value amounting to $3.8 billion.

  • Resmed's Current Assets rose 3464.61% to $3.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $3.8 billion, marking a year-over-year increase of 3464.61%. This contributed to the annual value of $3.5 billion for FY2025, which is 4868.63% up from last year.
  • Per Resmed's latest filing, its Current Assets stood at $3.8 billion for Q4 2025, which was up 3464.61% from $3.6 billion recorded in Q3 2025.
  • In the past 5 years, Resmed's Current Assets ranged from a high of $3.8 billion in Q4 2025 and a low of $1.5 billion during Q1 2021
  • Its 5-year average for Current Assets is $2.4 billion, with a median of $2.3 billion in 2023.
  • As far as peak fluctuations go, Resmed's Current Assets soared by 5027.77% in 2022, and later tumbled by 42.7% in 2024.
  • Resmed's Current Assets (Quarter) stood at $1.5 billion in 2021, then surged by 50.28% to $2.3 billion in 2022, then grew by 2.28% to $2.4 billion in 2023, then increased by 19.26% to $2.8 billion in 2024, then skyrocketed by 34.65% to $3.8 billion in 2025.
  • Its Current Assets stands at $3.8 billion for Q4 2025, versus $3.6 billion for Q3 2025 and $3.5 billion for Q2 2025.